Human cytochrome p450 2A13 efficiently metabolizes chemicals in air pollutants: Naphthalene, styrene, and toluene

被引:58
作者
Fukami, Tatsuki [1 ]
Katoh, Miki [1 ]
Yamazaki, Hiroshi [1 ]
Yokoi, Tsuyoshi [1 ]
Nakajima, Miki [1 ]
机构
[1] Kanazawa Univ, Grad Sch Med Sci, Div Pharmaceut Sci, Kanazawa, Ishikawa 9201192, Japan
关键词
D O I
10.1021/tx700325f
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Human P450 2A13 is the most efficient enzyme for catalyzing the metabolism of nicotine and metabolic activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). It is conceivable that P450 2A13 also metabolizes chemicals in air pollutants because this enzyme is highly expressed in the respiratory tract. In this study, we investigated the possibility that P450 2A13 can metabolize naphthalene, styrene, and toluene, which are included in air pollutants as well as tobacco smoke, although they were known to be metabolized by P450 1A2 or 2E1. We found that P450 2A13 catalyzed 1- and 2-naphthol formations from naphthalene with higher intrinsic clearances (kcat/Km) (3.1- and 2.2-fold, respectively) than P450 1A2 and also more efficiently catalyzed the styrene 7,8-oxide formation from styrene and the benzylalcohol formation from toluene than P450 2E1. The overlapping substrate specificity of P450 2A13 with P450 2E1 was supported by the finding that P450 2A13 catalyzed chlorzoxazone 6-hydroxylation (8-fold higher value of kcat/Km) and p-nitrophenol 2-hydroxylation (19-fold higher value of kcat/Km), which are marker activities of P450 2E1. Thus, we found that P450 2A13 metabolizes diverse environmental chemicals and has overlapping substrate specificities of P450 1A2 and 2E1, suggesting that P450 2A13 plays important roles in the local metabolism of environmental chemicals in the respiratory tract related to toxicity or carcinogenicity.
引用
收藏
页码:720 / 725
页数:6
相关论文
共 48 条
[1]   Predictive value of comparative molecular field analysis modelling of naphthalene inhibition of human CYP2A6 and mouse CYP2A5 enzymes [J].
Asikainen, A ;
Tarhanen, J ;
Poso, A ;
Pasanen, M ;
Alhava, E ;
Juvonen, RO .
TOXICOLOGY IN VITRO, 2003, 17 (04) :449-455
[2]   Metabolism of nicotine and cotinine by human cytochrome P450 2A13 [J].
Bao, ZP ;
He, XY ;
Ding, XX ;
Prabhu, S ;
Hong, JY .
DRUG METABOLISM AND DISPOSITION, 2005, 33 (02) :258-261
[3]   REVIEW OF THE TOXICOLOGY OF STYRENE [J].
BOND, JA .
CRC CRITICAL REVIEWS IN TOXICOLOGY, 1989, 19 (03) :227-249
[4]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[5]  
BUCKPITT A, 1995, MOL PHARMACOL, V47, P74
[6]   Genetic polymorphism of the human cytochrome CYP2A13 in a French population:: implication in lung cancer susceptibility [J].
Cauffiez, C ;
Lo-Guidice, JM ;
Quaranta, S ;
Allorge, D ;
Chevalier, D ;
Cenée, S ;
Hamdan, A ;
Lhermitte, M ;
Lafitte, JJ ;
Libersa, C ;
Colombel, JF ;
Stücker, I ;
Broly, F .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 317 (02) :662-669
[7]   In vitro metabolism of naphthalene by human liver microsomal cytochrome P450 enzymes [J].
Cho, TM ;
Rose, RL ;
Hodgson, E .
DRUG METABOLISM AND DISPOSITION, 2006, 34 (01) :176-183
[8]  
Court MH, 1997, BIOPHARM DRUG DISPOS, V18, P213, DOI 10.1002/(SICI)1099-081X(199704)18:3<213::AID-BDD15>3.0.CO
[9]  
2-0
[10]  
FERNANDEZSALGUERO P, 1995, AM J HUM GENET, V57, P651